Outcomes of Intrathecal Baclofen Therapy Compared With Deep Brain Stimulation in a Patient With Dystonic Cerebral Palsy: A Case Report
10.5535/arm.2019.43.3.335
- Author:
Minji CHAE
1
;
Seungbeen HONG
;
Na Young JUNG
;
Won Seok CHANG
;
Sung Rae CHO
Author Information
1. Department of Rehabilitation Medicine and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea. srcho918@yuhs.ac
- Publication Type:Case Report
- Keywords:
Dystonia;
Intrathecal baclofen pump;
Deep brain stimulation;
Cerebral palsy
- MeSH:
Baclofen;
Botulinum Toxins;
Cerebral Palsy;
Deep Brain Stimulation;
Dystonia;
Dystonic Disorders;
Globus Pallidus;
Hand;
Health Surveys;
Humans;
Muscle Spasticity;
Quality of Life;
Visual Analog Scale
- From:Annals of Rehabilitation Medicine
2019;43(3):335-340
- CountryRepublic of Korea
- Language:English
-
Abstract:
Deep brain stimulation (DBS) in internal globus pallidus is considered to be a good option for controlling generalized dystonia in patients with this condition. In this relation, it is known that DBS has already been shown to have significant effects on primary dystonia, but is seen as controversial in secondary dystonia including cerebral palsy (CP). On the other hand, intrathecal baclofen (ITB) has been known to reduce spasticity and dystonia in patients who did not respond to oral medications or botulinum toxin treatment. Here, we report a patient with dystonic CP, who received the ITB pump implantation long after the DBS and who noted remarkable improvement in the 36-Item Short Form Health Survey, Dystonia Rating Scale, Modified Barthel Index, and visual analog scale scores for pain after an ITB pump implantation was used as compared with DBS. To our knowledge, the present case report is the first to demonstrate the effects of an ITB pump on reducing pain and dystonia and improving quality of life and satisfaction, compared with DBS in a patient with CP.
